Complement factor C5 deficiency significantly delays the progression of biliary fibrosis in bile duct-ligated mice
Johannes Schmitt(University Hospital Zurich), Andreas Geier(Swiss Integrative Center for Human Health), M Roderfeld(Justus-Liebig-Universität Gießen), Karim Sabrane(University Hospital Zurich), Beat Müllhaupt(University Hospital of Zurich), Bruno Stieger(University Hospital of Zurich), Pascal Frei(University Hospital Zurich), Yinghua Tian, Achim Weber(University Hospital of Zurich), Pan Zhang(University Hospital Zurich), Joachim C. Mertens(GastroZentrum Hirslanden Zürich), Elke Roeb(Justus-Liebig-Universität Gießen)
Cited by 25
Related Papers
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
|Nature Reviews Gastroenterology & Hepatology|2020|2.5k
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
|Nature Reviews Gastroenterology & Hepatology|2016|1.4k
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2019|1.2k